WSR 25-14-080
PROPOSED RULES
DEPARTMENT OF HEALTH
(Washington Medical Commission)
[Filed June 30, 2025, 12:41 p.m.]
Original Notice.
Preproposal statement of inquiry was filed as WSR 24-11-104.
Title of Rule and Other Identifying Information: Office-based surgery rules for allopathic physicians (MD)—Use of nitrous oxide. The Washington medical commission (commission) is proposing new WAC 246-919-603 Use of nitrous oxide in office-based settings; and proposing changes to WAC 246-919-601 Safe and effective analgesia and anesthesia administration in office-based surgical settings.
Hearing Location(s): On August 22, 2025, at 9:30 a.m., virtually via Teams at https://tinyurl.com/bdkpf89c; or in person at Department of Health, Town Center 2, Rooms 166/167, 111 Israel Road S.E., Tumwater, WA 98501.
The public hearing will be hybrid. Participants can attend at the physical location, or virtually by registering at https://tinyurl.com/bdkpf89c.
To join the comission's rules interested parties email list, please visit https://public.govdelivery.com/accounts/WADOH/subscriber/new?topic_id=WADOH_153.
Date of Intended Adoption: August 22, 2025.
Submit Written Comments to: Amelia Boyd, Program Manager, P.O. Box 47866, Olympia, WA 98504-7866, email medical.rules@wmc.wa.gov, https://fortress.wa.gov/doh/policyreview/, beginning the date and time of this filing, by August 15, 2025, 11:59 p.m.
Assistance for Persons with Disabilities: Contact Amelia Boyd, program manager, phone 800-525-0127, TTY 711, email medical.rules@wmc.wa.gov, by August 15, 2025.
Purpose of the Proposal and Its Anticipated Effects, Including Any Changes in Existing Rules: The commission is proposing amendments to WAC 246-919-601 and creating new WAC 246-919-603 to establish the use of nitrous oxide by allopathic physicians in office-based surgical settings.
The proposal clarifies the regulatory status of nitrous oxide in office-based settings and establishes safety standards for its use. WAC 246-919-601 does not specify whether nitrous oxide qualifies as minimal sedation; new WAC 246-919-603 addresses this gap by outlining conditions for exemption. It ensures patient safety through physician training, the presence of a basic life support certified provider, patient monitoring, emergency protocols, and special precautions for pediatric patients. By defining safe use conditions, the rule provides regulatory clarity while allowing controlled use of nitrous oxide by allopathic physicians in office-based settings with minimal risk. WAC 246-919-601 is being amended to reference new WAC 246-919-603.
Reasons Supporting Proposal: This proposal provides regulatory clarity by explicitly defining nitrous oxide's status as minimal sedation, ensuring consistent application of rules. It enhances patient safety through physician training, patient monitoring, emergency protocols, and safeguards like scavenging systems and secure storage. Aligning with medical best practices, it allows controlled use of nitrous oxide, a widely accepted, low-risk sedation option. Clear guidelines improve access to safe, office-based sedation while minimizing risks, particularly for pediatric patients.
Rule is not necessitated by federal law, federal or state court decision.
Name of Proponent: Washington medical commission, governmental.
Name of Agency Personnel Responsible for Drafting: Amelia Boyd, 111 Israel Road S.E., Tumwater, WA 98501, 360-918-6336; Implementation and Enforcement: Kyle Karinen, 111 Israel Road S.E., Tumwater, WA 98501, 360-236-4810.
A school district fiscal impact statement is not required under RCW
28A.305.135.
A cost-benefit analysis is required under RCW
34.05.328. A preliminary cost-benefit analysis may be obtained by contacting Amelia Boyd, Program Manager, P.O. Box 47866, Olympia, WA 98504-7866, phone 360-918-6336, TTY 711, email
medical.rules@wmc.wa.gov.
This rule proposal, or portions of the proposal, is exempt from requirements of the Regulatory Fairness Act because the proposal:
Explanation of exemptions: The proposed rule regulates an individual's license, not a small business.
Scope of exemption for rule proposal:
Is fully exempt.
June 27, 2025
Kyle S. Karinen
Executive Director
Washington Medical Commission
RDS-6157.1
AMENDATORY SECTION(Amending WSR 20-22-003, filed 10/21/20, effective 11/21/20)
WAC 246-919-601Safe and effective analgesia and anesthesia administration in office-based surgical settings.
(1) Purpose. The purpose of this rule is to promote and establish consistent standards, continuing competency, and to promote patient safety. The commission establishes the following rule for physicians licensed under this chapter who perform surgical procedures and use anesthesia, analgesia or sedation in office-based settings.
(2) Definitions. The following terms used in this subsection apply throughout this section unless the context clearly indicates otherwise:
(a) "Deep sedation" or "analgesia" means a drug-induced depression of consciousness during which patients cannot be easily aroused but respond purposefully following repeated or painful stimulation. The ability to independently maintain ventilatory function may be impaired. Patients may require assistance in maintaining a patent airway, and spontaneous ventilation may be inadequate. Cardiovascular function is usually maintained.
(b) "General anesthesia" means a state of unconsciousness intentionally produced by anesthetic agents, with absence of pain sensation over the entire body, in which the patient is without protective reflexes and is unable to maintain an airway, and cardiovascular function may be impaired. Sedation that unintentionally progresses to the point at which the patient is without protective reflexes and is unable to maintain an airway is not considered general anesthesia.
(c) "Local infiltration" means the process of infusing a local anesthetic agent into the skin and other tissues to allow painless wound irrigation, exploration and repair, and other procedures, including procedures such as retrobulbar or periorbital ocular blocks only when performed by a board eligible or board certified ophthalmologist. It does not include procedures in which local anesthesia is injected into areas of the body other than skin or muscle where significant cardiovascular or respiratory complications may result.
(d) "Major conduction anesthesia" means the administration of a drug or combination of drugs to interrupt nerve impulses without loss of consciousness, such as epidural, caudal, or spinal anesthesia, lumbar or brachial plexus blocks, and intravenous regional anesthesia. Major conduction anesthesia does not include isolated blockade of small peripheral nerves, such as digital nerves.
(e) "Minimal sedation" means a drug-induced state during which patients respond normally to verbal commands. Although cognitive function and coordination may be impaired, ventilatory and cardiovascular functions are unaffected. Minimal sedation is limited to oral, intranasal, or intramuscular medications.
(f) "Moderate sedation" or "analgesia" means a drug-induced depression of consciousness during which patients respond purposefully to verbal commands, either alone or accompanied by tactile stimulation. No interventions are required to maintain a patent airway, and spontaneous ventilation is adequate. Cardiovascular function is usually maintained.
(g) "Office-based surgery" means any surgery or invasive medical procedure requiring analgesia or sedation, including, but not limited to, local infiltration for tumescent liposuction, performed in a location other than a hospital or hospital-associated surgical center licensed under chapter
70.41 RCW, or an ambulatory surgical facility licensed under chapter
70.230 RCW.
(3) Exemptions. This rule does not apply to physicians when:
(a) Performing surgery and medical procedures that require only minimal sedation (anxiolysis), or infiltration of local anesthetic around peripheral nerves. Infiltration around peripheral nerves does not include infiltration of local anesthetic agents in an amount that exceeds the manufacturer's published recommendations.
(b) Using nitrous oxide under the requirements in WAC 246-919-603.
(c) Performing surgery in a hospital or hospital-associated surgical center licensed under chapter
70.41 RCW, or an ambulatory surgical facility licensed under chapter
70.230 RCW.
((
(c)))
(d) Performing surgery utilizing or administering general anesthesia. Facilities in which physicians administer general anesthesia or perform procedures in which general anesthesia is a planned event are regulated by rules related to hospital or hospital-associated surgical center licensed under chapter
70.41 RCW, an ambulatory surgical facility licensed under chapter
70.230 RCW, or a dental office under WAC 246-919-602.
(((d)))(e) Administering deep sedation or general anesthesia to a patient in a dental office under WAC 246-919-602.
(((e)))(f) Performing oral and maxillofacial surgery, and the physician:
(i) Is licensed both as a physician under chapter
18.71 RCW and as a dentist under chapter
18.32 RCW;
(ii) Complies with dental quality assurance commission regulations;
(iii) Holds a valid:
(A) Moderate sedation permit; or
(B) Moderate sedation with parenteral agents permit; or
(C) General anesthesia and deep sedation permit; and
(iv) Practices within the scope of their specialty.
(4) Application of rule.
This rule applies to physicians practicing independently or in a group setting who perform office-based surgery employing one or more of the following levels of sedation or anesthesia:
(a) Moderate sedation or analgesia; or
(b) Deep sedation or analgesia; or
(c) Major conduction anesthesia.
(5) Accreditation or certification.
(a) A physician who performs a procedure under this rule must ensure that the procedure is performed in a facility that is appropriately equipped and maintained to ensure patient safety through accreditation or certification and in good standing from an accrediting entity approved by the commission.
(b) The commission may approve an accrediting entity that demonstrates to the satisfaction of the commission that it has all of the following:
(i) Standards pertaining to patient care, recordkeeping, equipment, personnel, facilities and other related matters that are in accordance with acceptable and prevailing standards of care as determined by the commission;
(ii) Processes that assure a fair and timely review and decision on any applications for accreditation or renewals thereof;
(iii) Processes that assure a fair and timely review and resolution of any complaints received concerning accredited or certified facilities; and
(iv) Resources sufficient to allow the accrediting entity to fulfill its duties in a timely manner.
(c) A physician may perform procedures under this rule in a facility that is not accredited or certified, provided that the facility has submitted an application for accreditation by a commission-approved accrediting entity, and that the facility is appropriately equipped and maintained to ensure patient safety such that the facility meets the accreditation standards. If the facility is not accredited or certified within one year of the physician's performance of the first procedure under this rule, the physician must cease performing procedures under this rule until the facility is accredited or certified.
(d) If a facility loses its accreditation or certification and is no longer accredited or certified by at least one commission-approved entity, the physician shall immediately cease performing procedures under this rule in that facility.
(6) Competency. When an anesthesiologist or certified registered nurse anesthetist is not present, the physician performing office-based surgery and using a form of sedation defined in subsection (4) of this section must be competent and qualified both to perform the operative procedure and to oversee the administration of intravenous sedation and analgesia.
(7) Qualifications for administration of sedation and analgesia may include:
(a) Completion of a continuing medical education course in conscious sedation;
(b) Relevant training in a residency training program; or
(c) Having privileges for conscious sedation granted by a hospital medical staff.
(8) At least one licensed health care practitioner currently certified in advanced resuscitative techniques appropriate for the patient age group must be present or immediately available with age-size-appropriate resuscitative equipment throughout the procedure and until the patient has met the criteria for discharge from the facility. Certification in advanced resuscitative techniques includes, but is not limited to, advanced cardiac life support (ACLS), pediatric advanced life support (PALS), or advanced pediatric life support (APLS).
(9) Sedation assessment and management.
Sedation is a continuum. Depending on the patient's response to drugs, the drugs administered, and the dose and timing of drug administration, it is possible that a deeper level of sedation will be produced than initially intended.
(a) If an anesthesiologist or certified registered nurse anesthetist is not present, a physician intending to produce a given level of sedation should be able to "rescue" a patient who enters a deeper level of sedation than intended.
(b) If a patient enters into a deeper level of sedation than planned, the physician must return the patient to the lighter level of sedation as quickly as possible, while closely monitoring the patient to ensure the airway is patent, the patient is breathing, and that oxygenation, heart rate and blood pressure are within acceptable values. A physician who returns a patient to a lighter level of sedation in accordance with this subsection (c) does not violate subsection (10) of this section.
(10) Separation of surgical and monitoring functions.
(a) The physician performing the surgical procedure must not administer the intravenous sedation, or monitor the patient.
(b) The licensed health care practitioner, designated by the physician to administer intravenous medications and monitor the patient who is under moderate sedation, may assist the operating physician with minor, interruptible tasks of short duration once the patient's level of sedation and vital signs have been stabilized, provided that adequate monitoring of the patient's condition is maintained. The licensed health care practitioner who administers intravenous medications and monitors a patient under deep sedation or analgesia must not perform or assist in the surgical procedure.
(11) Emergency care and transfer protocols. A physician performing office-based surgery must ensure that in the event of a complication or emergency:
(a) All office personnel are familiar with a written and documented plan to timely and safely transfer patients to an appropriate hospital.
(b) The plan must include arrangements for emergency medical services and appropriate escort of the patient to the hospital.
(12) Medical record. The physician performing office-based surgery must maintain a legible, complete, comprehensive, and accurate medical record for each patient.
(a) The medical record must include all of the following:
(i) Identity of the patient;
(ii) History and physical, diagnosis and plan;
(iii) Appropriate lab, X-ray or other diagnostic reports;
(iv) Appropriate preanesthesia evaluation;
(v) Narrative description of procedure;
(vi) Pathology reports, if relevant;
(vii) Documentation of which, if any, tissues and other specimens have been submitted for histopathologic diagnosis;
(viii) Provision for continuity of postoperative care; and
(ix) Documentation of the outcome and the follow-up plan.
(b) When moderate or deep sedation, or major conduction anesthesia is used, the patient medical record must include a separate anesthesia record that documents:
(i) The type of sedation or anesthesia used;
(ii) Name, dose, and time of administration of drugs;
(iii) Documentation at regular intervals of information obtained from the intraoperative and postoperative monitoring;
(iv) Fluids administered during the procedure;
(v) Patient weight;
(vi) Level of consciousness;
(vii) Estimated blood loss;
(viii) Duration of procedure; and
(ix) Any complication or unusual events related to the procedure or sedation/anesthesia.
NEW SECTION
WAC 246-919-603Use of nitrous oxide in office-based settings.
(1) The purpose of this rule is to promote and establish consistent standards, continuing competency, and promote patient safety. The commission establishes the following rule for physicians licensed under this chapter who perform surgical procedures and use nitrous oxide in office-based settings.
(2) The use of nitrous oxide is exempt from WAC 246-919-601 requirements if the following conditions are met:
(a) Nitrous oxide is administered at a concentration of 50 percent or less;
(b) Nitrous oxide is used without another inhaled anesthetic, sedative, or opioid drug; and
(c) The following safeguards are in place:
(i) The physician performing the procedure must demonstrate competence by completing a continuing medical education course in nitrous oxide administration;
(ii) At least one healthcare practitioner must be present who is certified in basic life support (BLS);
(iii) The physician must be capable of resuscitating a patient from deeper sedation levels and ensure the patient's vital signs are monitored;
(iv) The physician performing the procedure must not administer nitrous oxide or monitor the patient;
(v) The licensed provider administering the nitrous oxide must be different from the physician performing the procedure;
(vi) The facility must have a documented plan for transferring patients to a hospital in case of complications, including arrangements for emergency medical services and appropriate escort of the patient to the hospital;
(vii) The physician must maintain legible, complete, comprehensive, and accurate medical records including the following:
(A) Identity of the patient;
(B) History and physical, diagnosis and plan;
(C) Appropriate lab, X-ray, or other diagnostic reports;
(D) Documentation of nitrous oxide administered or dispensed; and
(E) Documentation of vital signs during the nitrous oxide sedation, including respiratory rate, oxygen saturation, heart rate, and blood pressure;
(viii) The following equipment must be available and include:
(A) Suction equipment capable of aspirating gastric contents from the mouth and pharynx;
(B) Portable oxygen delivery system including full face masks and a bag-valve-mask combination with appropriate connectors capable of delivery positive pressure, oxygen enriched ventilation to the patient;
(C) Blood pressure cuff or sphygmomanometer of appropriate size; and
(D) Pulse oximeter;
(ix) Nitrous oxide must not be administered to any patient under three years of age. For pediatric patients older than three years, a discussion with the parent or guardian is required to address the specific risks associated with nitrous oxide use in cases where the patient:
(A) Is younger than six years old; or
(B) Has airway abnormalities.
This discussion must include reasoning why the pediatric patient can safely receive nitrous oxide in an outpatient environment and any alternatives.
(x) Excess nitrous oxide must be removed from the procedure room to protect staff via a scavenging system;
(xi) Equipment used for monitoring patients must be calibrated or performance verified according to manufacturer's instructions; and
(xii) Nitrous oxide must be stored securely and accessible only by authorized individuals.
(3) The physician shall ensure they assess patient responsiveness using preoperative values as normal guidelines and discharge the patient only when the following criteria are met, except when their prior baseline is below the noted criteria:
(a) Vital signs including blood pressure, pulse rate, and respiratory rate are stable. Vital signs are not required when a pediatric patient is uncooperative or the emotional condition is such that obtaining vital signs is not possible;
(b) The patient is alert and oriented to person, place, and time as appropriate to age and preoperative psychological status;
(c) The patient can talk and respond coherently to verbal questioning as appropriate to age and preoperative psychological status;
(d) The patient can sit up unassisted;
(e) The patient can walk with minimal assistance;
(f) The patient does not have uncontrollable nausea or vomiting and has minimal dizziness.